Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 514

1.

Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003.

Richter SS, Heilmann KP, Beekmann SE, Miller NJ, Miller AL, Rice CL, Doern CD, Reid SD, Doern GV.

Clin Infect Dis. 2005 Sep 1;41(5):599-608.

PMID:
16080080
2.

High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.

Liu X, Shen X, Chang H, Huang G, Fu Z, Zheng Y, Wang L, Li C, Liu L, Shen Y, Yang Y.

Pediatr Pulmonol. 2009 May;44(5):436-41. doi: 10.1002/ppul.20976.

PMID:
19360846
3.

Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.

Green M, Martin JM, Barbadora KA, Beall B, Wald ER.

Antimicrob Agents Chemother. 2004 Feb;48(2):473-6.

4.

Macrolide-resistant genes of Streptococcus pyogenes isolated from the upper respiratory tract by polymerase chain reaction.

Billal DS, Hotomi M, Yamauchi K, Fujihara K, Tamura S, Kuki K, Sugita R, Endou M, Mukaigawa J, Yamanaka N.

J Infect Chemother. 2004 Apr;10(2):115-20.

PMID:
15160306
5.

Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).

Wierzbowski AK, Nichol K, Laing N, Hisanaga T, Nikulin A, Karlowsky JA, Hoban DJ, Zhanel GG.

J Antimicrob Chemother. 2007 Oct;60(4):733-40. Epub 2007 Aug 2.

PMID:
17673477
6.

Macrolide-resistant Streptococcus pyogenes from Chinese pediatric patients in association with Tn916 transposons family over a 16-year period.

Feng L, Lin H, Ma Y, Yang Y, Zheng Y, Fu Z, Yu S, Yao K, Shen X.

Diagn Microbiol Infect Dis. 2010 Aug;67(4):369-75. doi: 10.1016/j.diagmicrobio.2010.03.014.

PMID:
20638606
7.

Molecular characterization of macrolide- and multidrug-resistant Streptococcus pyogenes isolated from adult patients in Barcelona, Spain (1993-2008).

Ardanuy C, Domenech A, Rolo D, Calatayud L, Tubau F, Ayats J, Martín R, Liñares J.

J Antimicrob Chemother. 2010 Apr;65(4):634-43. doi: 10.1093/jac/dkq006. Epub 2010 Jan 29.

PMID:
20118164
8.

Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.

Descheemaeker P, Chapelle S, Lammens C, Hauchecorne M, Wijdooghe M, Vandamme P, Ieven M, Goossens H.

J Antimicrob Chemother. 2000 Feb;45(2):167-73.

PMID:
10660498
9.

Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).

Malhotra-Kumar S, Mazzariol A, Van Heirstraeten L, Lammens C, de Rijk P, Cornaglia G, Goossens H.

J Antimicrob Chemother. 2009 Jan;63(1):42-6. doi: 10.1093/jac/dkn432. Epub 2008 Oct 24.

PMID:
18952616
10.

A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002.

Szczypa K, Sadowy E, Izdebski R, Hryniewicz W.

J Antimicrob Chemother. 2004 Oct;54(4):828-31. Epub 2004 Aug 25.

PMID:
15329367
11.

Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.

Mason EO Jr, Wald ER, Bradley JS, Barson WJ, Kaplan SL; United States Pediatric Multicenter Pneumococcal Surveillance Study Group.

Pediatr Infect Dis J. 2003 Jul;22(7):623-7.

PMID:
12867838
12.

Phenotypes and genotypes of macrolide-resistant Streptococcus pyogenes isolated in Seoul, Korea.

Bae SY, Kim JS, Kwon JA, Yoon SY, Lim CS, Lee KN, Cho Y, Kim YK, Lee CK.

J Med Microbiol. 2007 Feb;56(Pt 2):229-35.

PMID:
17244805
13.

Phenotypic and molecular characterization of macrolide and streptogramin resistance in Streptococcus mitis from neutropenic patients.

Achour W, Guenni O, Malbruny B, Canu A, Leclercq R, Hassen AB.

J Antimicrob Chemother. 2004 Jul;54(1):117-21. Epub 2004 Jun 9.

PMID:
15190021
14.

Macrolide-resistant Streptococcus pneumoniae and Streptococcus pyogenes in the pediatric population in Germany during 2000-2001.

Reinert RR, Lütticken R, Bryskier A, Al-Lahham A.

Antimicrob Agents Chemother. 2003 Feb;47(2):489-93.

15.

Macrolide resistance in Streptococcus pyogenes: prevalence, resistance determinants, and emm types.

Michos AG, Bakoula CG, Braoudaki M, Koutouzi FI, Roma ES, Pangalis A, Nikolopoulou G, Kirikou E, Syriopoulou VP.

Diagn Microbiol Infect Dis. 2009 Jul;64(3):295-9. doi: 10.1016/j.diagmicrobio.2009.03.004. Epub 2009 Apr 22.

PMID:
19395219
16.

Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics.

Sauermann R, Gattringer R, Graninger W, Buxbaum A, Georgopoulos A.

J Antimicrob Chemother. 2003 Jan;51(1):53-7.

PMID:
12493787
17.

[Macrolide resistance phenotypes and genotypes in group G streptococci].

Açikgöz ZC, Göçer S, Almayanlar E.

Mikrobiyol Bul. 2003 Apr-Jun;37(2-3):117-24. Turkish.

PMID:
14593892
18.

Antimicrobial susceptibility patterns, emm type distribution and genetic diversity of Streptococcus pyogenes recovered in Brazil.

Arêas GP, Schuab RB, Neves FP, Barros RR.

Mem Inst Oswaldo Cruz. 2014 Nov;109(7):935-9. Epub 2014 Oct 28.

19.

What causes decreased erythromycin resistance in Streptococcus pyogenes? Dynamics of four clones in a southern European region from 2005 to 2012.

Montes M, Tamayo E, Mojica C, García-Arenzana JM, Esnal O, Pérez-Trallero E.

J Antimicrob Chemother. 2014 Jun;69(6):1474-82. doi: 10.1093/jac/dku039. Epub 2014 Feb 20.

PMID:
24562616
20.

[Phenotypes and genetic mechanisms of resistance to macrolides and lincosamides in viridans group streptococci].

Artiles Campelo F, Horcajada Herrera I, Alamo Antúnez I, Cãnas Pedrosa A, Lafarga Capuz B.

Rev Esp Quimioter. 2007 Sep;20(3):317-22. Spanish.

Supplemental Content

Support Center